BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 990 filers reported holding BAXTER INTL INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $209,945 | -1.0% | 4,119 | +4.5% | 0.15% | -31.5% |
| Q3 2022 | $212,000 | -16.2% | 3,941 | 0.0% | 0.22% | -31.3% |
| Q2 2022 | $253,000 | -17.3% | 3,941 | 0.0% | 0.32% | +1.3% |
| Q1 2022 | $306,000 | -9.5% | 3,941 | 0.0% | 0.32% | -11.6% |
| Q4 2021 | $338,000 | +6.6% | 3,941 | 0.0% | 0.36% | -32.1% |
| Q3 2021 | $317,000 | +456.1% | 3,941 | +228.4% | 0.53% | +241.0% |
| Q3 2016 | $57,000 | +5.6% | 1,200 | 0.0% | 0.16% | -8.2% |
| Q2 2016 | $54,000 | +10.2% | 1,200 | 0.0% | 0.17% | +3.7% |
| Q1 2016 | $49,000 | +6.5% | 1,200 | 0.0% | 0.16% | +12.3% |
| Q4 2015 | $46,000 | +15.0% | 1,200 | 0.0% | 0.15% | +11.5% |
| Q3 2015 | $40,000 | -52.4% | 1,200 | 0.0% | 0.13% | -47.2% |
| Q2 2015 | $84,000 | +2.4% | 1,200 | 0.0% | 0.25% | +4.6% |
| Q1 2015 | $82,000 | -6.8% | 1,200 | 0.0% | 0.24% | -4.4% |
| Q4 2014 | $88,000 | +2.3% | 1,200 | 0.0% | 0.25% | +6.9% |
| Q3 2014 | $86,000 | 0.0% | 1,200 | 0.0% | 0.23% | +5.5% |
| Q2 2014 | $86,000 | -3.4% | 1,200 | 0.0% | 0.22% | -8.3% |
| Q1 2014 | $89,000 | +6.0% | 1,200 | 0.0% | 0.24% | +9.1% |
| Q4 2013 | $84,000 | +6.3% | 1,200 | 0.0% | 0.22% | -4.3% |
| Q3 2013 | $79,000 | -4.8% | 1,200 | 0.0% | 0.23% | -3.4% |
| Q2 2013 | $83,000 | – | 1,200 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |